Search

everythinglearnresearchcommunity

for

Search:↓

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

A woman experienced temporary hair loss after jaw surgery due to the stress of the operation.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Higher levels of ischemia-modified albumin in telogen effluvium patients may indicate oxidative stress.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

Weight loss can cause temporary hair loss, especially in women and older adults.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

New understanding and treatments for hair loss are improving, but more research is needed.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

Nuclear Factor I-C is important for controlling hair growth by affecting the TGF-β1 pathway.

The study found that a specific area of the hair follicle helps start hair growth by reducing the blocking effects on certain cells and controlling growth signals.

The protein SLC1A3 is important for activating skin stem cells and is necessary for normal hair and skin growth in mice.

Melatonin and cortisol affect mink winter hair growth, but β-endorphin levels do not.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

FGF12 is important for hair growth and could be targeted for hair loss treatment.

NF-κB is crucial for different stages and types of hair growth in mice.

The conclusion is that Fgf18 and Tgf-ß signaling could be targeted for hair loss treatments.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

miR-486 may help prevent hair loss in alopecia areata.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

Resveratrol may help hair grow, but more research is needed.